sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 06/06/2011
PIL Danol 100mg Capsules, Danol 200mg Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/06/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 26/05/2011 and displayed until 06/06/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 15/11/2010 and displayed until 26/05/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 22/01/2008 and displayed until 15/11/2010
Reasons for adding or updating:
  • Company name change or merger
  • Change due to user-testing of patient information
Updated on 02/08/2006 and displayed until 22/01/2008
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 04/08/2005 and displayed until 02/08/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 30/09/2004 and displayed until 04/08/2005
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 06/06/2003 and displayed until 30/09/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 16/10/2002 and displayed until 06/06/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   danazol